OpenAlex
PricingAboutJobs
Log inGet started
Work

Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients

HTML

Year: 2002
Type: article
Study design: Clinical Trial
Source: European Journal of Cancer
DOI: 10.1016/s0959-8049(02)00491-4
Authors: A.T van Oosterom, H.T Mouridsen, O.S Nielsen, P Dombernowsky, K Krzemieniecki, I Judson, L Svancarova, D Spooner, C Hermans, M Van Glabbeke, J Verweij
Institutions: Universitair Ziekenhuis Leuven, Rigshospitalet, Aarhus University Hospital, Herlev Hospital, The Maria Sklodowska-Curie National Research Institute of Oncology, Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, European Organisation for Research and Treatment of Cancer, Daniel den Hoed Kliniek
Language: English

Topic: Sarcoma Diagnosis and Treatment
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: ifosfamide, soft tissue sarcoma, metastatic sarcoma, dosing regimen, first-line chemotherapy, second-line chemotherapy, leiomyosarcoma, response rate, survival, leukopenia, infection, drug toxicity
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2091453908
FWCI: 3.907
Cites: 30
Cited by: 180
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms